 |
|
EFFECT OF LARGE DOSES OF AUREOMYCIN, TERRAMYCIN, AND CHLORAMPHENICOL ON LIVERS OF MICE AND DOGS
MARK H. LEPPER, M.D.;
HYMAN J. ZIMMERMAN, M.D.;
GEORGE CARROLL, M.D.;
ESTON R. CALDWELL, Jr., M.D.;
HAROLD W. SPIES, M.D.;
CHARLES K. WOLFE, M.D.;
HARRY F. DOWLING, M.D.
AMA Arch Intern Med. 1951;88(3):284-295.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
DURING the course of clinical trials to determine the value of intravenous aureomycin therapy in various infections, we encountered several patients who exhibited jaundice, which, in some cases, was accompanied with pathologic changes in the liver. Our suspicions were aroused that the hepatic changes might be related to the administration of aureomycin because they did not appear to be the result of the disease for which the patient was being treated. Furthermore, all the patients who displayed jaundice had received very large doses of aureomycin. The details of these cases are reported in the preceding article in this issue.1 As a result of those observations, we decided to investigate the possible toxic effects of aureomycin on the livers of mice and dogs.
Several reports in the literature suggested that mice tolerate aureomycin well. Up to 200 mg. per kilogram of body weight per day given orally for eight weeks
. . . [Full Text PDF of this Article]
Author Affiliations
CHICAGO; WASHINGTON, D. C.; CHICAGO
From the Department of Preventive Medicine, University of Illinois College of Medicine, Chicago; the George Washington and Georgetown Medical Divisions, Gallinger Municipal Hospital, and the Departments of Medicine, George Washington and Georgetown Universities, Washington, D. C.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
